Literature DB >> 12322896

Increased expression of cyclooxygenase-2 in local lesions of endometriosis patients.

Fumihisa Chishima1, Satoshi Hayakawa, Kenji Sugita, Noriko Kinukawa, Sheike Aleemuzzaman, Norimichi Nemoto, Tatsuo Yamamoto, Mitsuo Honda.   

Abstract

PROBLEM: Human endometrial glands contain the highest levels of cyclooxygenase (COX), although whether it is COX-1 and/or COX-2 has not been previously determined. Overexpression of COX-2 may result in the pathogenesis of endometriosis. METHOD OF STUDY: Tissue sections were obtained from 28 premenopausal women undergoing laparotomy or laparoscopic surgery for benign conditions. Endometrium, ectopic endometriosis tissue and peritoneum were obtained at the time of surgery. Informed consents were obtained from all the patients participating in this study. Immunohistochemistry was performed on consecutive sections of paraffin-embedded tissue using anti-COX-2 antibody. Expressions of COX-2 mRNA in endometrium, ectopic endometriosis tissue, and peritoneum were quantitavely determined by competitive reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: In the uterus, COX-2 was localized in the endometrial epithelium. Eutopic endometrial surface epithelium contains more COX-2 than does glandular epithelium. We observed more frequent and denser COX-2 staining in the ectopic endometriosis implants when compared with eutopic endometrium. Level of COX-2 mRNA in endometriosis was increased up to five times that of eutopic endometria.
CONCLUSION: Hyper activation of COX-2 with abnormal prostaglandin generation is considered to contribute to the pathophysiology of endometriosis and disease progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12322896     DOI: 10.1034/j.1600-0897.2002.01101.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  19 in total

1.  A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis.

Authors:  Sang Jun Han; Shannon M Hawkins; Khurshida Begum; Sung Yun Jung; Ertug Kovanci; Jun Qin; John P Lydon; Francesco J DeMayo; Bert W O'Malley
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway.

Authors:  Jie Mei; Ming-Qing Li; Ding Ding; Da-Jin Li; Li-Ping Jin; Wei-Guo Hu; Xiao-Yong Zhu
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

3.  Surgical removal of endometriotic lesions alters local and systemic proinflammatory cytokines in endometriosis patients.

Authors:  Stephany P Monsanto; Andrew K Edwards; Juhua Zhou; Prakash Nagarkatti; Mitzi Nagarkatti; Steven L Young; Bruce A Lessey; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2015-12-14       Impact factor: 7.329

4.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms.

Authors:  JeHoon Lee; Sakhila K Banu; Robert C Burghardt; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Biol Reprod       Date:  2013-03-28       Impact factor: 4.285

Review 5.  Endometriosis: current therapies and new pharmacological developments.

Authors:  Paolo Vercellini; Edgardo Somigliana; Paola Viganò; Annalisa Abbiati; Giussy Barbara; Pier Giorgio Crosignani
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.

Authors:  Sakhila K Banu; JeHoon Lee; V O Speights; Anna Starzinski-Powitz; Joe A Arosh
Journal:  Mol Endocrinol       Date:  2009-04-30

Review 7.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

8.  Telemetric assessment of referred vaginal hyperalgesia and the effect of indomethacin in a rat model of endometriosis.

Authors:  N Dmitrieva; E K Faircloth; S Pyatok; F Sacher; V Patchev
Journal:  Front Pharmacol       Date:  2012-08-30       Impact factor: 5.810

Review 9.  EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

Authors:  Madison N Sluter; Ruida Hou; Lexiao Li; Nelufar Yasmen; Ying Yu; Jiawang Liu; Jianxiong Jiang
Journal:  J Med Chem       Date:  2021-08-05       Impact factor: 8.039

10.  Interleukin-8 producing malignant fibrous histiocytoma with prolonged fever.

Authors:  Shunzo Osaka; Satoshi Hayakawa; Yukihiro Yoshida; Eisaku Sakurada; Junnosuke Ryu; Masahiko Sugitani
Journal:  Acta Histochem Cytochem       Date:  2006-02-15       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.